Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 0

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Relationship between sleep-related impairment and cognitive functioning among breast cancer survivors

Telles, Victoria M., Mac, Victoria, Tam, Rowena, Torres-Ruiz, Marisa, Hartman, Sheri J.·2026·Journal of Cancer Survivorship
DOI 10.1007/s11764-026-02057-7
Open this paper in CoChat — free account

Abstract

Purpose: Sleep-related impairment and cancer-related cognitive decline (CRCD) are common, disruptive symptoms affecting breast cancer survivors. This study examined the association between sleep-related impairment and both self-reported and objective cognitive functioning in breast cancer survivors following treatment. Methods: Participants ( N = 253) from the I Can! Improving Cognition After Cancer study completed the NIH Toolbox Digit Symbol test to measure Processing Speed and a battery of neurocognitive tests of Memory, Executive Functioning, and Attention domains. Self-reported cognition was assessed with the PROMIS Cognitive Function and Abilities scales. Sleep-related impairment was measured by the PROMIS Sleep-Related Impairment scale. Multiple linear regression models were used to examine the associations between sleep-related impairment and the six cognitive outcomes, adjusting for demographic and cancer treatment factors. Results: Participants were on average 59 (SD = 8.9) years old, majority identified as White (77%) and were college graduates (42%). Fifty-seven percent of participants underwent chemotherapy, 80% received hormone therapy, and 81% were treated with radiation. Greater sleep-related impairment was significantly associated with worse executive function ( β = −0.01, 95% CI: −0.022, −0.000, p = 0.04), worse cognitive abilities ( β = −0.28, 95% CI: −0.375, −0.184, p < 0.001), and worse cognitive function ( β = −0.25, 95% CI: −0.323, −0.167, p < 0.001). No significant associations were observed for memory, attention, or processing Speed. Conclusion: Greater sleep-related impairment was associated with poorer self-reported cognitive functioning and modest differences in executive functioning among breast cancer survivors, underscoring the importance of addressing sleep-related impairment in this population. Implications for Cancer Survivors: Assessing sleep-related impairment during survivorship care may help identify survivors experiencing cognitive difficulties and related daytime functional concerns.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11764-026-02057-7

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 48

  1. Binarelli G, Duivon M, Joly F, Ahmed-Lecheheb D, Lange M. Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment. Expert Rev Neurother. 2023;23(3):249–68. https://doi.org/10.1080/14737175.2023.2187288. · DOI
  2. Lange M, Licaj I, Clarisse B, Humbert X, Grellard JM, Tron L, et al. Cognitive complaints in cancer survivors and expectations for support: results from a web-based survey. Cancer Med. 2019;8(5):2654–63. https://doi.org/10.1002/cam4.2069. · DOI
  3. Hartman SJ, Weiner LS, Natarajan L, Sears DD, Palmer BW, Parker B, et al. A randomized trial of physical activity for cognitive functioning in breast cancer survivors: rationale and study design of I can! Improving cognition after cancer. Contemp Clin Trials. 2021;102:106289–106289. https://doi.org/10.1016/j.cct.2021.106289. · DOI
  4. Boscher C, Joly F, Clarisse B, Humbert X, Grellard JM, Binarelli G, et al. Perceived cognitive impairment in breast cancer survivors and its relationships with psychological factors. Cancers (Basel). 2020. https://doi.org/10.3390/cancers12103000. · DOI
  5. Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol. 2011;38(3):431–8. https://doi.org/10.1053/j.seminoncol.2011.03.014. · DOI · Paper page
  6. Yang Y, Hendrix CC. Cancer-related cognitive impairment in breast cancer patients: influences of psychological variables. Asia Pac J Oncol Nurs Jul-Sep. 2018;5(3):296–306. https://doi.org/10.4103/apjon.apjon_16_18. · DOI
  7. Van Dyk K, Ganz PA. Cancer-related cognitive impairment in patients with a history of breast cancer. JAMA. 2021;326(17):1736–7. https://doi.org/10.1001/jama.2021.13309. · DOI
  8. Von Ah D, Habermann B, Carpenter JS, Schneider BL. Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs. 2013;17(2):236–41. https://doi.org/10.1016/j.ejon.2012.06.002. · DOI
  9. Henneghan AM, Carter P, Stuifbergan A, Parmelee B, Kesler S. Relationships between self-reported sleep quality components and cognitive functioning in breast cancer survivors up to 10 years following chemotherapy. Psychooncology. 2018;27(8):1937–43. https://doi.org/10.1002/pon.4745. · DOI
  10. Hartman SJ, Marinac CR, Natarajan L, Patterson RE. Lifestyle factors associated with cognitive functioning in breast cancer survivors. Psychooncology. 2015;24(6):669–75. https://doi.org/10.1002/pon.3626. · DOI
  11. Carroll JE, Small BJ, Tometich DB, Zhai W, Zhou X, Luta G, et al. Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: interaction with genotype. Cancer. 2019;125(24):4516–24. https://doi.org/10.1002/cncr.32489. · DOI
  12. Xu S, Thompson W, Ancoli-Israel S, Liu L, Palmer B, Natarajan L. Cognition, quality-of-life, and symptom clusters in breast cancer: using Bayesian networks to elucidate complex relationships. Psychooncology. 2018;27(3):802–9. https://doi.org/10.1002/pon.4571. · DOI
  13. Henneghan A. Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review. Support Care Cancer. 2016;24(1):481–97. https://doi.org/10.1007/s00520-015-2927-y. · DOI
  14. Drijver AJ, Oort Q, Otten R, Reijneveld JC, Klein M. Is poor sleep quality associated with poor neurocognitive outcome in cancer survivors? A systematic review. J Cancer Surviv. 2022. https://doi.org/10.1007/s11764-022-01213-z. · DOI · Paper page
  15. Cheng WH, Teo RH, Cheng LJ, Lau Y, Lau ST. Global prevalence of sleep disturbances among breast cancer survivors: a systematic review with meta-analysis. Sleep Health. 2023;9(5):704–16. https://doi.org/10.1016/j.sleh.2023.04.004. · DOI
  16. Leysen L, Lahousse A, Nijs J, Adriaenssens N, Mairesse O, Ivakhnov S, et al. Prevalence and risk factors of sleep disturbances in breast cancer survivors: systematic review and meta-analyses. Support Care Cancer. 2019;27(12):4401–33. https://doi.org/10.1007/s00520-019-04936-5. · DOI
  17. Caplette-Gingras A, Savard J, Savard MH, Ivers H. Is insomnia associated with cognitive impairments in breast cancer patients? Behav Sleep Med. 2013;11(4):239–57. https://doi.org/10.1080/15402002.2012.672940. · DOI
  18. Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38(7):926–34. https://doi.org/10.1016/j.ctrv.2012.05.002. · DOI
  19. Bender CM, Pacella ML, Sereika SM, Brufsky AM, Vogel VG, Rastogi P, et al. What do perceived cognitive problems reflect? J Support Oncol. 2008;6(5):238–42.
  20. Tannock IF, Ahles TA, Ganz PA, Van Dam FS. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004;22(11):2233–9. https://doi.org/10.1200/jco.2004.08.094. · DOI
  21. Van Dyk K, Crespi CM, Bower JE, Castellon SA, Petersen L, Ganz PA. The cognitive effects of endocrine therapy in survivors of breast cancer: a prospective longitudinal study up to 6 years after treatment. Cancer. 2019;125(5):681–9. https://doi.org/10.1002/cncr.31858. · DOI
  22. Hardy SJ, Krull KR, Wefel JS, Janelsins M. Cognitive changes in cancer survivors. Am Soc Clin Oncol Educ Book. 2018;38:795–806. https://doi.org/10.1200/edbk_201179. · DOI
  23. Liou KT, Ahles TA, Garland SN, Li QS, Bao T, Li Y, et al. The relationship between insomnia and cognitive impairment in breast cancer survivors. JNCI Cancer Spectr. 2019;3(3):pkz041. https://doi.org/10.1093/jncics/pkz041. · DOI · Paper page
  24. Spira AP, Chen-Edinboro LP, Wu MN, Yaffe K. Impact of sleep on the risk of cognitive decline and dementia. Curr Opin Psychiatry. 2014;27(6):478–83. https://doi.org/10.1097/yco.0000000000000106. · DOI · Paper page
  25. Xu W, Tan CC, Zou JJ, Cao XP, Tan L. Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2020;91(3):236–44. https://doi.org/10.1136/jnnp-2019-321896. · DOI
  26. Gonzalez BD, Eisel SL, Qin B, Llanos AAM, Savard J, Hoogland AI, et al. Prevalence, risk factors, and trajectories of sleep disturbance in a cohort of African-American breast cancer survivors. Support Care Cancer. 2021;29(5):2761–70. https://doi.org/10.1007/s00520-020-05786-2. · DOI
  27. Williams AM, Shah R, Shayne M, Huston AJ, Krebs M, Murray N, et al. Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy. J Neuroimmunol. 2018;314:17–23. https://doi.org/10.1016/j.jneuroim.2017.10.005. · DOI
  28. Morgan EM, Mara CA, Huang B, Barnett K, Carle AC, Farrell JE, et al. Establishing clinical meaning and defining important differences for Patient-Reported Outcomes Measurement Information System (PROMIS®) measures in juvenile idiopathic arthritis using standard setting with patients, parents, and providers. Qual Life Res. 2017;26(3):565–86. https://doi.org/10.1007/s11136-016-1468-2. · DOI
  29. Bender CM, Sereika SM, Gentry AL, Cuglewski C, Duquette J, Grove G, et al. Effects of aerobic exercise on neurocognitive function in postmenopausal women receiving endocrine therapy for breast cancer: the exercise program in cancer and cognition randomized controlled trial. Psychooncology. 2024. https://doi.org/10.1002/pon.6298. · DOI
  30. Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins verbal learning test—revised: normative data and analysis of inter-form and test–retest reliability. Clin Neuropsychol. 1998;12(1):43–55. https://doi.org/10.1076/clin.12.1.43.1726. · DOI · Paper page
  31. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 2016;8(3):271–6. · DOI
  32. Weintraub S, Dikmen SS, Heaton RK, Tulsky DS, Zelazo PD, Slotkin J, et al. The cognition battery of the NIH toolbox for assessment of neurological and behavioral function: validation in an adult sample. J Int Neuropsychol Soc. 2014;20(6):567–78. https://doi.org/10.1017/s1355617714000320. · DOI · Paper page
  33. Lai JS, Wagner LI, Jacobsen PB, Cella D. Self-reported cognitive concerns and abilities: two sides of one coin? Psychooncology. 2014;23(10):1133–41. https://doi.org/10.1002/pon.3522. · DOI
  34. Von Ah D, Tallman EF. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument. J Pain Symptom Manage. 2015;49(4):697–706. https://doi.org/10.1016/j.jpainsymman.2014.08.012. · DOI
  35. Strollo SE, Fallon EA, Gapstur SM, Smith TG. Cancer-related problems, sleep quality, and sleep disturbance among long-term cancer survivors at 9-years post diagnosis. Sleep Med. 2020;65:177–85. https://doi.org/10.1016/j.sleep.2019.10.008. · DOI
  36. Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH. Sleep and quality of life in breast cancer patients. J Pain Symptom Manage. 2002;24(5):471–80. https://doi.org/10.1016/S0885-3924(02)00500-6. · DOI
  37. Sanford SD, Wagner LI, Beaumont JL, Butt Z, Sweet JJ, Cella D. Longitudinal prospective assessment of sleep quality: before, during, and after adjuvant chemotherapy for breast cancer. Support Care Cancer. 2013;21(4):959–67. https://doi.org/10.1007/s00520-012-1612-7. · DOI
  38. Yang Y, Ah DV. Cancer-related cognitive impairment: updates to treatment, the need for more evidence, and impact on quality of life—a narrative review. Ann Palliat Med. 2024;13(5):1265–80. · DOI
  39. Syarif H, Waluyo A, Afiyanti Y, Mansyur M. Executive function in breast cancer survivors and the influencing factors. Enferm Clin. 2019;29:280–5. https://doi.org/10.1016/j.enfcli.2019.04.034. · DOI
  40. Diamond A. Effects of physical exercise on executive functions: going beyond simply moving to moving with thought. Ann Sports Med Res. 2015;2(1):1011.
  41. Diamond A. Executive functions. Annu Rev Psychol. 2013;64:135–68. https://doi.org/10.1146/annurev-psych-113011-143750. · DOI · Paper page
  42. Wasserman RM, Hilliard ME, Schwartz DD, Anderson BJ. Practical strategies to enhance executive functioning and strengthen diabetes management across the lifespan. Curr Diab Rep. 2015;15(8):52–52, 52. https://doi.org/10.1007/s11892-015-0622-5. · DOI
  43. Radin A, Ganz PA, Van Dyk K, Stanton AL, Bower JE. Executive functioning and depressive symptoms after cancer: the mediating role of coping. Psychosom Med. 2021;83(3):291–9. https://doi.org/10.1097/psy.0000000000000926. · DOI · Paper page
  44. Sen A, Tai XY. Sleep duration and executive function in adults. Curr Neurol Neurosci Rep. 2023;23(11):801–13. https://doi.org/10.1007/s11910-023-01309-8. · DOI
  45. Syarif H, Waluyo AH, Afiyanti Y, Mansyur M. Verbal learning and memory function and the influencing factors on breast cancer survivors: a cross-sectional study. Asian Pac Isl Nurs J. 2019;4(2):77–83. https://doi.org/10.31372/20190402.1036. · DOI
  46. Van Dyk K, Bower JE, Crespi CM, Petersen L, Ganz PA. Cognitive function following breast cancer treatment and associations with concurrent symptoms. NPJ Breast Cancer. 2018;4:25–25, 25. https://doi.org/10.1038/s41523-018-0076-4. · DOI
  47. Tonning Olsson I, Lubas MM, Li C, Mandrell BN, Banerjee P, Howell CR, et al. Insomnia and neurocognitive functioning in adult survivors of childhood cancer. JNCI Cancer Spectr. 2020;4(3):pkaa008. https://doi.org/10.1093/jncics/pkaa008 · DOI
  48. Cheung YT, Brinkman TM, Mulrooney DA, Mzayek Y, Liu W, Banerjee P, et al. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia. Cancer. 2017;123(17):3410–9. https://doi.org/10.1002/cncr.30742. · DOI

Metadata

Authors
Telles, V. M., Mac, V., Tam, R., Torres-Ruiz, M., & Hartman, S. J.
Venue
Journal of Cancer Survivorship
Publisher
Springer Science and Business Media LLC
Published
2026-06-13
Volume
20
Issue
S2
Pages
2217-2224
ISSN
  • 1932-2259
  • 1932-2267
DOI
10.1007/s11764-026-02057-7
Cited by
0
References
5
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.